Cargando…
Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437317/ https://www.ncbi.nlm.nih.gov/pubmed/34518841 http://dx.doi.org/10.1101/2021.09.02.21262146 |
_version_ | 1783752148558807040 |
---|---|
author | Lyski, Zoe L. Kim, Sunny Lee, David Xthona Sampson, David Raué, Hans P. Raghunathan, Vikram Ryan, Debbie Brunton, Amanda E. Slifka, Mark K. Messer, William B. Spurgeon, Stephen E. |
author_facet | Lyski, Zoe L. Kim, Sunny Lee, David Xthona Sampson, David Raué, Hans P. Raghunathan, Vikram Ryan, Debbie Brunton, Amanda E. Slifka, Mark K. Messer, William B. Spurgeon, Stephen E. |
author_sort | Lyski, Zoe L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8437317 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-84373172021-09-14 Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients Lyski, Zoe L. Kim, Sunny Lee, David Xthona Sampson, David Raué, Hans P. Raghunathan, Vikram Ryan, Debbie Brunton, Amanda E. Slifka, Mark K. Messer, William B. Spurgeon, Stephen E. medRxiv Article Cold Spring Harbor Laboratory 2021-09-07 /pmc/articles/PMC8437317/ /pubmed/34518841 http://dx.doi.org/10.1101/2021.09.02.21262146 Text en https://creativecommons.org/licenses/by-nd/4.0/This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, and only so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Lyski, Zoe L. Kim, Sunny Lee, David Xthona Sampson, David Raué, Hans P. Raghunathan, Vikram Ryan, Debbie Brunton, Amanda E. Slifka, Mark K. Messer, William B. Spurgeon, Stephen E. Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients |
title | Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients |
title_full | Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients |
title_fullStr | Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients |
title_full_unstemmed | Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients |
title_short | Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients |
title_sort | immunogenicity of pfizer mrna covid-19 vaccination followed by j&j adenovirus covid-19 vaccination in two cll patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437317/ https://www.ncbi.nlm.nih.gov/pubmed/34518841 http://dx.doi.org/10.1101/2021.09.02.21262146 |
work_keys_str_mv | AT lyskizoel immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients AT kimsunny immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients AT leedavidxthona immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients AT sampsondavid immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients AT rauehansp immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients AT raghunathanvikram immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients AT ryandebbie immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients AT bruntonamandae immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients AT slifkamarkk immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients AT messerwilliamb immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients AT spurgeonstephene immunogenicityofpfizermrnacovid19vaccinationfollowedbyjjadenoviruscovid19vaccinationintwocllpatients |